Kota Nakamura, Masayuki Sho, Sohei Satoi, Hisashi Kosaka, Takahiro Akahori, Minako Nagai, Kenji Nakagawa, Tadataka Takagi, Tomohisa Yamamoto, So Yamaki
BACKGROUND: This retrospective multicenter study aimed to evaluate the risk of postpancreatectomy hemorrhage (PPH) in patients receiving antithrombotic agents (ATAs). PPH is the most severe complication after pancreatectomy. However, there is little known about the strength of the association between ATA use, PPH, and other clinical outcomes. STUDY DESIGN: Between 2007 and 2016, 1,297 patients underwent pancreatectomy at 2 surgical centers. ATA use included aspirin, clopidogrel, ticlopidine, warfarin, direct oral anticoagulants, and intravenous unfractionated heparin...
October 2020: Journal of the American College of Surgeons